Skip to main content
. 2020 Jul 28;39(9):2803–2810. doi: 10.1007/s10067-020-05230-0

Key Points

• COVID-19 patients with SLE is advocated to continue the medical treatment for SLE.

• Hydroxychloroquine may have potential benefits for COVID-19 patients with SLE.

• COVID-19 patients with SLE is prone to relapse, and multiple follow-ups are necessary.